Xenon Pharmaceuticals Inc. (XENE) — DEF 14A Filings
All DEF 14A filings from Xenon Pharmaceuticals Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Xenon Pharma Executive Compensation Details Revealed
— Apr 24, 2025 Risk: low
Xenon Pharmaceuticals Inc. filed a DEF 14A on April 24, 2025, detailing executive compensation. The filing includes information on changes in the fair value of -
Xenon Pharmaceuticals Inc. Files Definitive Proxy Statement
— Apr 26, 2024 Risk: low
Xenon Pharmaceuticals Inc. (XENE) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Xenon Pharmaceuticals Inc. filed a Definitive Proxy Statemen
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX